Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
POSTED
09-29-22
Gilead Sciences: WHO Expands Recommendation for Veklury® (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline
Gilead Sciences, Inc. (Nasdaq: GILD) today announced updates to the World Health Organization’s (WHO) Therapeutics and COVID-19: living guideline.
POSTED
09-26-22
4 Questions With Dr. Javier Cortes: The Importance of Scientific Exchange To Advance Breast Cancer
As the oncology community gathers for the ESMO Congress in Paris, we sat down with Javier to learn why scientific exchange and the gathering of researchers is so necessary, both for people living with cancer and for those who work in the field.
POSTED
09-16-22
Mentoring Mothers Living With HIV: Angelina's Story
“For me, meeting my peers, women who were living with HIV and who also had children – that was a turning point for me,” Angelina says. “I needed that kind of support. It really helped me to cope back then.”
POSTED
09-08-22
Overcoming Blood Cancer With CAR T-cell Therapy: Eleonora's Journey
In February 2019, Eleonora was preparing to go out with a friend when she suddenly fainted. She woke up in the hospital near her home in Italy and didn’t remember a thing. But she will never forget the news the doctors delivered to her.
POSTED
09-01-22
4 Questions With Jared Baeten: Innovating, Collaborating and Inspiring at Aids 2022
We connected with Jared Baeten, Gilead’s Vice President of HIV Clinical Development to discuss the top highlights from AIDS 2022, and ways the company is looking to help transform care and improve outcomes for people affected by HIV.
POSTED
08-26-22
The Top 10 Big Pharmas for Their Diversity, Equity and Inclusion Efforts in 2022
Pharma’s reputation may have soared amid the pandemic, but that came with a brighter spotlight on diversity, equity and inclusion issues. In recent years, pharma has been trying to incorporate DEI more deeply into its corporate psyche.
POSTED
08-24-22
Father Helps Build GenderCool to Grow Awareness Around Trans Youth
In the corporate partnership landscape, GenderCool is increasing awareness of trans issues through its reverse mentorship program, where a champion is paired with a company for eight weeks.
POSTED
08-22-22
Ashley Innes Relishes Opportunity to Make Her Mark on HIV Epidemic in Southern U.S.
Read more to discover how Ashley has been able to broaden her impact on the HIV epidemic while working in an environment where she feels comfortable being her full, authentic self.
POSTED
08-19-22
Gilead Sciences Announces Collaboration With Morehouse School of Medicine and Xavier University of Louisiana College of Pharmacy To Address Inequities in HIV Care
Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new health equity collaboration with the Satcher Health Leadership Institute (SHLI) at Morehouse School of Medicine and the Center for
POSTED
08-17-22
Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency
Gilead Sciences, Inc., GLAAD, the Human Rights Campaign, the National Black Justice Coalition, the National Center for Lesbian Rights and NMAC recently announced immediate action in response to the emerging monkeypox virus outbreak.